Celiac Disease Pipeline Review Market Research Report for H2 2015

Jan 14, 2016, 01:00 ET from ReportsnReports

PUNE, India, January 14, 2016 /PRNewswire/ --

The Celiac Disease - Pipeline Review, H2 2015 report provides an overview of the Celiac Disease's therapeutic pipeline and helps enhance decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Complete report on Celiac Disease Pipeline Review spread across 83 pages, analyzing 14 companies and supported with 30 tables and 14 figures is now available at http://www.reportsnreports.com/reports/453496-celiac-disease-pipeline-review-h2-2015.html .

This report provides comprehensive information on the therapeutic development for Celiac Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Celiac Disease and special features on late-stage and discontinued projects.

Top Companies covered in this report are Alba Therapeutics Corporation, Alvine Pharmaceuticals, Inc., Amgen Inc., Amyra Biotech AG, Avaxia Biologics, Inc., Calypso Biotech SA, enGene, Inc, Glenmark Pharmaceuticals Ltd., ImmusanT, Inc., Intrexon Corporation, Provid Pharmaceuticals, Inc., Selecta Biosciences, Inc., Sitari Pharmaceuticals, Inc. and Zedira GmbH. Order a copy of Celiac Disease - Pipeline Review, H2 2015 market research report at http://www.reportsnreports.com/purchase.aspx?name=453496 .

Scope: The report provides a snapshot of the global therapeutic landscape of Celiac Disease. The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities and also key players involved in the therapeutics development for Celiac Disease and enlists all their major and minor projects. The report summarizes all the dormant and discontinued pipeline projects and review of the Celiac Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages. A detailed assessment of monotherapy and combination therapy pipeline projects and coverage of the Celiac Disease pipeline on the basis of target, MoA, route of administration and molecule type and latest news and deals relating related to pipeline products.

Another newly published market research titled Mild Psoriasis - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Mild Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Mild Psoriasis and special features on late-stage and discontinued projects. The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities and reviews key players involved in the therapeutics development for Mild Psoriasis and enlists all their major and minor projects. Mild Psoriasis Review research report of 48 pages is available at http://www.reportsnreports.com/reports/452387-mild-psoriasis-pipeline-review-h2-2015.html .

Explore more reports on pharmaceuticals market at http://www.reportsnreports.com/market-research/pharmaceuticals/ .

About Us:   

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com

Connect With Us on:  

Facebook: https://www.facebook.com/ReportsnReports/

LinkedIn: https://www.linkedin.com/company/reportsnreports

Twitter: https: //twitter.com/marketsreports

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts

RSS/Feeds:  http: //http://www.reportsnreports.com/feed/l-latestreports.xml


SOURCE ReportsnReports